DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $33.00 by Analysts at Robert W. Baird

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective cut by investment analysts at Robert W. Baird from $35.00 to $33.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird’s price objective points to a potential upside of 16.65% from the stock’s previous close.

A number of other research analysts have also issued reports on the stock. Barrington Research reiterated an “outperform” rating and set a $41.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a research note on Friday, January 12th. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 price target on the stock. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average target price of $36.90.

DENTSPLY SIRONA Stock Down 0.3 %

Shares of NASDAQ:XRAY opened at $28.29 on Friday. The stock has a market cap of $5.87 billion, a P/E ratio of -64.29, a P/E/G ratio of 1.15 and a beta of 1.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.95. DENTSPLY SIRONA has a 1-year low of $26.27 and a 1-year high of $41.65. The firm has a fifty day moving average price of $32.13 and a 200 day moving average price of $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period in the previous year, the business posted $0.39 earnings per share. The business’s revenue was down 2.6% compared to the same quarter last year. Sell-side analysts predict that DENTSPLY SIRONA will post 2.05 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

Several large investors have recently modified their holdings of XRAY. Exchange Traded Concepts LLC grew its position in shares of DENTSPLY SIRONA by 41.2% in the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 439 shares during the last quarter. Asset Management One Co. Ltd. lifted its stake in shares of DENTSPLY SIRONA by 5.0% during the third quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock valued at $3,069,000 after buying an additional 4,294 shares during the period. Xponance Inc. lifted its stake in shares of DENTSPLY SIRONA by 12.4% during the third quarter. Xponance Inc. now owns 37,292 shares of the medical instruments supplier’s stock valued at $1,274,000 after buying an additional 4,114 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of DENTSPLY SIRONA by 132.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 83,817 shares of the medical instruments supplier’s stock valued at $2,863,000 after buying an additional 47,748 shares during the period. Finally, Strs Ohio raised its stake in DENTSPLY SIRONA by 14.6% during the third quarter. Strs Ohio now owns 47,167 shares of the medical instruments supplier’s stock worth $1,611,000 after purchasing an additional 6,021 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.